ES487847A0 - Un procedimiento para preparar nuevas fenetanolaminas - Google Patents
Un procedimiento para preparar nuevas fenetanolaminasInfo
- Publication number
- ES487847A0 ES487847A0 ES487847A ES487847A ES487847A0 ES 487847 A0 ES487847 A0 ES 487847A0 ES 487847 A ES487847 A ES 487847A ES 487847 A ES487847 A ES 487847A ES 487847 A0 ES487847 A0 ES 487847A0
- Authority
- ES
- Spain
- Prior art keywords
- phenethanolamins
- procedure
- preparing new
- preparing
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92166878A | 1978-07-03 | 1978-07-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8101537A1 ES8101537A1 (es) | 1980-12-16 |
| ES487847A0 true ES487847A0 (es) | 1980-12-16 |
Family
ID=25445786
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES482153A Expired ES482153A1 (es) | 1978-07-03 | 1979-07-03 | Un procedimiento para preparar nuevas fenetanolaminas. |
| ES487847A Granted ES487847A0 (es) | 1978-07-03 | 1980-01-18 | Un procedimiento para preparar nuevas fenetanolaminas |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES482153A Expired ES482153A1 (es) | 1978-07-03 | 1979-07-03 | Un procedimiento para preparar nuevas fenetanolaminas. |
Country Status (33)
| Country | Link |
|---|---|
| EP (2) | EP0047536B1 (es) |
| JP (1) | JPS559100A (es) |
| AR (2) | AR222658A1 (es) |
| AT (1) | AT370408B (es) |
| AU (1) | AU521744B2 (es) |
| BE (1) | BE877392A (es) |
| BG (3) | BG40480A3 (es) |
| CA (1) | CA1120058A (es) |
| CH (1) | CH641759A5 (es) |
| CS (2) | CS208660B2 (es) |
| DD (1) | DD144763A5 (es) |
| DK (1) | DK268579A (es) |
| EG (1) | EG14400A (es) |
| ES (2) | ES482153A1 (es) |
| FI (1) | FI67686C (es) |
| FR (1) | FR2430409A1 (es) |
| GB (1) | GB2028800B (es) |
| GR (1) | GR72546B (es) |
| HK (1) | HK44087A (es) |
| HU (1) | HU179170B (es) |
| IE (1) | IE48436B1 (es) |
| IL (1) | IL57670A (es) |
| LU (1) | LU81456A1 (es) |
| MX (1) | MX6160E (es) |
| MY (1) | MY8500596A (es) |
| NZ (1) | NZ190859A (es) |
| PH (1) | PH15650A (es) |
| PL (2) | PL123990B1 (es) |
| PT (1) | PT69840A (es) |
| RO (2) | RO77731A (es) |
| SU (2) | SU965351A3 (es) |
| YU (1) | YU154879A (es) |
| ZA (1) | ZA793295B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2965655D1 (en) * | 1978-06-28 | 1983-07-21 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
| NL8105170A (nl) * | 1980-12-10 | 1982-07-01 | Thomae Gmbh Dr K | Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen. |
| EP0068669A1 (en) * | 1981-06-20 | 1983-01-05 | Beecham Group Plc | Secondary phenylethanol amines, processes for their preparation and their pharmaceutical application |
| CA1219865A (en) * | 1982-05-14 | 1987-03-31 | Leo Alig | Aziridine phenethanolamine derivatives |
| CA1258454A (en) * | 1982-08-10 | 1989-08-15 | Leo Alig | Phenethanolamines |
| EP0102213A1 (en) * | 1982-08-21 | 1984-03-07 | Beecham Group Plc | Ethanolamine derivatives, pharmaceutical compositions containing them, and processes for preparing them |
| EP0117647B1 (en) * | 1983-01-31 | 1988-08-17 | Eli Lilly And Company | Improvements in or relating to phenethanolamines |
| US4849453A (en) * | 1983-01-31 | 1989-07-18 | Eli Lilly And Company | Growth promotion |
| US4569801A (en) * | 1984-10-15 | 1986-02-11 | Eli Lilly And Company | Alkylsulfonamidophenylalkylamines |
| JPS62155213A (ja) * | 1985-12-20 | 1987-07-10 | イ−ライ・リリ−・アンド・カンパニ− | 腫瘍細胞崩壊剤 |
| EG18188A (en) * | 1986-05-01 | 1992-09-30 | Pfizer Ltd | Process for preparation anti-arhythmia agents |
| US5135955A (en) * | 1988-04-25 | 1992-08-04 | Eli Lilly And Company | Propanamine derivatives |
| US5051423A (en) * | 1988-07-13 | 1991-09-24 | Schering Ag | Derivatized alkanolamines as cardiovascular agents |
| US5541197A (en) * | 1994-04-26 | 1996-07-30 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| CN1073983C (zh) * | 1994-10-31 | 2001-10-31 | 中国科学院成都有机化学研究所 | 一种β－拟肾上腺素兴奋剂型饲料添加剂的合成方法 |
| EP1402890B1 (en) | 2001-06-08 | 2008-01-09 | Institute of Medicinal Molecular Design, Inc. | Sulfonamide derivatives |
| TW200740779A (en) | 2005-07-22 | 2007-11-01 | Mitsubishi Pharma Corp | Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6610530A (es) * | 1966-07-27 | 1968-01-29 | ||
| BE757005A (fr) * | 1969-10-02 | 1971-04-02 | Bristol Myers Co | Phenethanolamines substituees et procede pour leur preparation |
| US3801631A (en) * | 1972-02-16 | 1974-04-02 | Mead Johnson & Co | 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts |
-
1979
- 1979-06-26 DK DK268579A patent/DK268579A/da not_active Application Discontinuation
- 1979-06-26 CA CA000330569A patent/CA1120058A/en not_active Expired
- 1979-06-26 IL IL57670A patent/IL57670A/xx unknown
- 1979-06-27 PH PH22700A patent/PH15650A/en unknown
- 1979-06-27 EG EG386/79A patent/EG14400A/xx active
- 1979-06-27 NZ NZ190859A patent/NZ190859A/en unknown
- 1979-06-28 YU YU01548/79A patent/YU154879A/xx unknown
- 1979-06-28 AU AU48488/79A patent/AU521744B2/en not_active Ceased
- 1979-06-28 PT PT69840A patent/PT69840A/pt unknown
- 1979-06-29 FR FR7916992A patent/FR2430409A1/fr active Granted
- 1979-06-29 HU HU79EI866A patent/HU179170B/hu unknown
- 1979-07-02 SU SU792786502A patent/SU965351A3/ru active
- 1979-07-02 RO RO7998011A patent/RO77731A/ro unknown
- 1979-07-02 BG BG7944165A patent/BG40480A3/xx unknown
- 1979-07-02 LU LU81456A patent/LU81456A1/xx unknown
- 1979-07-02 JP JP8489479A patent/JPS559100A/ja active Granted
- 1979-07-02 EP EP81109790A patent/EP0047536B1/en not_active Expired
- 1979-07-02 GB GB7922953A patent/GB2028800B/en not_active Expired
- 1979-07-02 MX MX798145U patent/MX6160E/es unknown
- 1979-07-02 RO RO105066A patent/RO83053B/ro unknown
- 1979-07-02 FI FI792080A patent/FI67686C/fi not_active IP Right Cessation
- 1979-07-02 EP EP79301282A patent/EP0007206B1/en not_active Expired
- 1979-07-02 BG BG7945919A patent/BG40481A3/xx unknown
- 1979-07-02 CS CS794630A patent/CS208660B2/cs unknown
- 1979-07-02 BE BE1/9443A patent/BE877392A/fr not_active IP Right Cessation
- 1979-07-02 BG BG7945920A patent/BG40482A3/xx unknown
- 1979-07-02 CH CH616479A patent/CH641759A5/fr not_active IP Right Cessation
- 1979-07-02 CS CS794630A patent/CS208661B2/cs unknown
- 1979-07-02 GR GR59488A patent/GR72546B/el unknown
- 1979-07-03 AR AR277165A patent/AR222658A1/es active
- 1979-07-03 AT AT0463979A patent/AT370408B/de not_active IP Right Cessation
- 1979-07-03 ZA ZA793295A patent/ZA793295B/xx unknown
- 1979-07-03 PL PL1979222867A patent/PL123990B1/pl unknown
- 1979-07-03 ES ES482153A patent/ES482153A1/es not_active Expired
- 1979-07-03 DD DD79214071A patent/DD144763A5/de unknown
- 1979-07-03 PL PL1979216810A patent/PL119783B1/pl unknown
- 1979-08-08 IE IE1231/79A patent/IE48436B1/en unknown
-
1980
- 1980-01-18 ES ES487847A patent/ES487847A0/es active Granted
- 1980-09-12 SU SU802977044A patent/SU931102A3/ru active
- 1980-10-06 AR AR282776A patent/AR222727A1/es active
-
1985
- 1985-12-30 MY MY596/85A patent/MY8500596A/xx unknown
-
1987
- 1987-06-04 HK HK440/87A patent/HK44087A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES490503A0 (es) | Un procedimiento para preparar nuevos compuestos de cefem | |
| ES500726A0 (es) | Un procedimiento para preparar diaminopiridinas | |
| MX5604E (es) | Procedimiento para preparar aril-hidantoina | |
| ES493061A0 (es) | Un procedimiento para preparar un lipopolisacarido | |
| ES490166A0 (es) | Un procedimiento para preparar mercaptoacildipeptidos | |
| ES487847A0 (es) | Un procedimiento para preparar nuevas fenetanolaminas | |
| ES500727A0 (es) | Un procedimiento para preparar imidazo-piridinas | |
| ES486425A0 (es) | Un procedimiento para preparar nuevas 4-arilpiperinas. | |
| ES484270A0 (es) | Un procedimiento para preparar compuestos de cefem | |
| ES497300A0 (es) | Un procedimiento para preparar 9-aminoalquilfluorenos | |
| AR223978A1 (es) | Un procedimiento para preparar un mercaptano | |
| ES494459A0 (es) | Un procedimiento para preparar cetoximinoeteres | |
| ES493759A0 (es) | Un procedimiento para preparar benzoxazepinas | |
| ES505496A0 (es) | Un procedimiento para preparar nuevos compuestos de cefem | |
| AR224149A1 (es) | Un procedimiento para producir piran-4-onas | |
| ES487349A0 (es) | Un procedimiento para preparar un material cromogeno | |
| ES489590A0 (es) | Un procedimiento para preparar arilalquil- y ariloxi-alquil-fosfonatos | |
| ES500464A0 (es) | Un procedimiento para preparar 2-halogeno-acetanilidas | |
| AR223161A1 (es) | Procedimiento para preparar n-etiletilendiamina | |
| ES493191A0 (es) | Un metodo para preparar feniliminotiadiazolinas | |
| AR226418A1 (es) | Un procedimiento para preparar compuestos de 2,4-dicloro-piridina | |
| ES481212A0 (es) | Un procedimiento para preparar benzoxepinas | |
| AR223975A1 (es) | Procedimiento para preparar acilureidoalquil-bencen-sulfonilureas | |
| MX5406E (es) | Procedimiento para preparar cloracetanilidas | |
| ES486713A0 (es) | Un procedimiento para preparar furopiridinonas y furopirazi-nonas |